NFKB1 and breast carcinoma: Thus, SH inhibits NFκB activation through multiple mechanisms, meanwhile, NFκB p65 overexpression reversed the SH-mediated decrease in MMP-2/-9 levels and impaired the invasiveness of U87 and SF767 cells, consistent with previous results showing that sinomenine suppresses breast cancer cell metastasis by blocking NFκB activation [9].